These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3177335)

  • 21. Pathogenesis and management of primary osteoporosis.
    Bauwens SF; Drinka PJ; Boh LE
    Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The concept and treatment of osteoporosis.
    Rittinghaus EF; Hesch RD; Harms HM; Busch U; Prokop M; Delling G
    Exp Gerontol; 1990; 25(3-4):357-65. PubMed ID: 2226671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of bone histology in the determination of bone metabolism].
    Allolio B
    Med Klin (Munich); 2003 Feb; 98(2):110; author reply 110-1. PubMed ID: 12638545
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of activate-depress-free-repeat (ADFR) treatment on bone mass in old beagles with osteoporosis].
    Kuranobu K
    Nihon Seikeigeka Gakkai Zasshi; 1990 May; 64(5):430-41. PubMed ID: 2380595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ; Kinnunen K; Volin L; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Ruutu T
    Bone Marrow Transplant; 1999 Feb; 23(4):355-61. PubMed ID: 10100579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcitriol in the treatment of postmenopausal osteoporosis.
    Aloia JF; Vaswani A; Yeh JK; Ellis K; Yasumura S; Cohn SH
    Am J Med; 1988 Mar; 84(3 Pt 1):401-8. PubMed ID: 3279769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
    Tóth E; Csupor E; Mészáros S; Ferencz V; Németh L; McCloskey EV; Horváth C
    Bone; 2005 Jan; 36(1):47-51. PubMed ID: 15664001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
    Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
    J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
    Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
    J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcitonin on osteoporotic bone fragility.
    Fujita T
    Calcif Tissue Int; 1990 Oct; 47(4):256. PubMed ID: 2242498
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of bone histology in the determination of bone metabolism].
    Barthel HR; Seibel MJ
    Med Klin (Munich); 2003 Feb; 98(2):111-2; author reply 113. PubMed ID: 12638546
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental study of thyroid hormone and bone metabolism in the rat].
    Ding G
    Zhonghua Yi Xue Za Zhi; 1990 Apr; 70(4):198-200, 16. PubMed ID: 2167757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is systemic treatment of osteoporosis and mandibular resorption possible?
    Driessens FC; Verbeeck RM; Van Dijk JW
    Acta Stomatol Belg; 1990 Jun; 87(2):107-24. PubMed ID: 2256451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fracture prevention in postmenopausal osteoporosis: a review of treatment options.
    McCarus DC
    Obstet Gynecol Surv; 2006 Jan; 61(1):39-50. PubMed ID: 16359568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of osteoporosis: strategies for individualized treatment].
    Weber K; Hoffmann A; Leb G
    Wien Med Wochenschr; 1999; 149(16-17):489-92. PubMed ID: 10627987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporosis and calcium-regulating hormones.
    Vigo P; Corghi E; Favini P; Girardello R; Ortolani S; Polli EE
    N Engl J Med; 1981 Dec; 305(24):1469-70. PubMed ID: 6895405
    [No Abstract]   [Full Text] [Related]  

  • 39. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis: trials and tribulations.
    Seeman E
    Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.